Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-4-3
pubmed:abstractText
Dihydroartemisinin-piperaquine (DHA-PPQ) is a promising new artemisinin combination treatment. There are no published data on the intentional use of the drug in pregnancy. Between June 2006 and January 2007, 50 Karen pregnant women with recurrent P. falciparum infections, despite 7-day treatments with quinine or artesunate (+/-clindamycin) or both, were treated with DHA-PPQ. This rescue treatment was effective and well tolerated and there was no evidence of toxicity for the mothers or the fetus. The PCR adjusted cure rate by Kaplan Meier analysis at day 63 was 92.2% (95% CI: 76.9-97.4).
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1476-1645
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
78
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
543-5
pubmed:meshHeading
pubmed-meshheading:18385345-Adolescent, pubmed-meshheading:18385345-Adult, pubmed-meshheading:18385345-Animals, pubmed-meshheading:18385345-Antimalarials, pubmed-meshheading:18385345-Artemisinins, pubmed-meshheading:18385345-Drug Therapy, Combination, pubmed-meshheading:18385345-Female, pubmed-meshheading:18385345-Fever, pubmed-meshheading:18385345-Gestational Age, pubmed-meshheading:18385345-Gravidity, pubmed-meshheading:18385345-Humans, pubmed-meshheading:18385345-Malaria, Falciparum, pubmed-meshheading:18385345-Parity, pubmed-meshheading:18385345-Plasmodium falciparum, pubmed-meshheading:18385345-Plasmodium vivax, pubmed-meshheading:18385345-Pregnancy, pubmed-meshheading:18385345-Pregnancy Complications, Infectious, pubmed-meshheading:18385345-Quinolines, pubmed-meshheading:18385345-Retrospective Studies, pubmed-meshheading:18385345-Thailand
pubmed:year
2008
pubmed:articleTitle
Dihydroartemisinin-piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report.
pubmed:affiliation
Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't